Functional studies of leukotriene receptors in vascular tissues

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 II, 2000, Pages

  Walch, Laurence ^a   Norel, Xavier ^a   Gascard, Jean Pierre ^a   Brink, Charles ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; INDOMETACIN; LEUKOTRIENE RECEPTOR; NITRIC OXIDE; PEPTIDOLEUKOTRIENE;

ANIMAL TISSUE; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; LUNG BLOOD VESSEL; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; REVIEW; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASCULAR TISSUE;

EID: 0034063819     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_1.ltta-21     Document Type: Review

References (52)

1. Dale, H. H., and P. P. Laidlaw. 1911. The physiologic action of β-imidazolylethylamine. J. Physiol. 41:318-344.
2. Schild, H. O., D. F. Hawkins, J. L. Mongar, and H. Herxheimer. 1951. Reactions of isolated human lung and bronchial tissue to a specific antigen. Lancet 261:376-382.
3. Brocklehurst, W. E. 1960. The release of histamine and formation of a slow reacting substance (SRS-A) during anaphylactic shock. J. Physiol. 151:416-435.
4. 4. Proc. Natl. Acad. Sci. U.S.A. 80:1712-1716.
5. Undem, B. J., W. C. Pickett, L. M. Lichtenstein, and G. K. Adams. 1987. The effect of indomethacin on immunological release of histamine and sulphidopeptide leukotrienes from human bronchus and lung parenchyma. Am. Rev. Respir. Dis. 138:1183-1187.
6. Orange, R. P., R. C. Murphy, M. L. Karnovsky, and K. F. Austen. 1973. The physiochemical characteristics and purification of SRS-A. J. Immunol. 110:760-770.
7. Murphy, R. C., S. Hammarström, and B. Samuelsson. 1979. Leukotriene C: a slow reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. U.S.A. 76:4275-4279.
8. Lam, S., H. Chan, J. C. Leriche, M. Chan-Yeung, and H. Salari. 1988. Release of leukotrienes in patients with bronchial asthma. J. Allergy Clin. Immunol. 81:711-717.
9. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1:584-588.
10. Sampson, A. P., C. P. Green, D. A. Spencer, P. J. Piper, and J. F. Price. 1991. Leukotrienes in the blood and urine of children with acute asthma. Ann. N.Y. Acad. Sci. 629:437-439.
11. 4 levels during early and late asthmatic responses. J. Allergy Clin. Immunol. 86:211-220.
12. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am. Rev. Respir. Dis. 141:1453-1458.
13. 4 in neonates with hypoxemia and pulmonary hypertension. N. Engl. J. Med. 309:77-80.
14. 4 on the pulmonary and systemic circulations. Am. Rev. Respir. Dis. 131:554-558.
15. Berkowitz, B. A., B. Zabko-Potapovich, R. Volocik, and J. G. Gleason. 1984. Effects of the leukotrienes on the vasculature and blood pressure of different species. J. Pharmacol. Exp. Ther. 229:105-112.
16. 4 affects pulmonary and cardiovascular dynamics in monkey. Nature (London) 295:327-329.
17. Gause, G. E., R. Baker, and S. Cassin. 1988. Specificity of FPL57231 for leukotriene receptors in fetal pulmonary circulation. Am. J. Physiol. 254:120-125.
18. Ohtaka, H., J. Y. Tsang, A. Foster, J. C. Hogg, and R. R. Schellenberg. 1987. Comparative effects of leukotrienes on porcine pulmonary circulation in vitro and in vivo. J. Appl. Physiol. 63:582-588.
19. 4 in the pulmonary vascular bed. Circ. Res. 55:707-717.
20. Serraf, A., J.-P. Gascard, J. Bruníaux, C. Labat, C. Planche, and C. Brink. 1997. Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved. Mediators Inflamm. 101:601-606.
21. Wescolt, J. Y., T. J. McDonnell, and N. F. Voekel. 1989. Alveolar transfer and metabolism of eicosanoids in the rat. Am. Rev. Respir. Dis. 139:80-87.
22. Piper, P. J., J. W. Antoniw, and A. W. B. Stanton. 1988. Release of leukotrienes from porcine and human blood vessels by immunological and nonimmunological stimuli. Ann. N.Y. Acad. Sci. 524:133-141.
23. Gorenne, I., C. Labat, J.-P. Gascard, and C. Brink. 1996. Antigen stimulation of human pulmonary smooth muscle: an in vitro model of inflammation. Cell Biol. Toxicol. 12:239-244.
24. Serlt, K., M. L. Kowalski, J. Slater, and M. Kaliner. 1988. Passive sensitization and antigen challenge increase vascular permeability in rat airways. Am. Rev. Respir. Dis. 138:1295-1299.
25. Shibamoto, T., T. Hayashi, F. Sawano, Y. Saeki, Y. Matsuda, M. Kawamoto, and S. Koyama. 1992. Pulmonary vascular response to anaphylaxis in isolated canine lungs. Am. J. Physiol. 263:1024-1029.
26. Alexander, D. I., P. Eyre, and V. P. Gordon. 1983. Anaphylactic contraction (Schultz-Dale reaction) of the bovine bronchial artery in vitro. Br. J. Pharmacol. 80:7-9.
27. Hand, J. M., and C. K. Buckner. 1979. Effects of selective antagonists on ovalbumin induced contraction of tracheal strips isolated from the actively sensitized guinea pig. Int. J. Immunopharmacol. 1:189-195.
28. Hand, J. M., J. A. Will, and C. K. Buckner. 1981. Effects of leukotrienes on isolated guinea pig pulmonary arteries. Eur. J. Pharmacol. 76:439-442.
29. Hand, J. M., J. A. Will, and C. K. Buckner. 1981. Pharmacological alteration of antigen induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig. J. Pharmacol. Exp. Ther. 220: 526-535.
30. Ortiz, J. L., C. Labat, X. Norel, I. Gorenne, J. Verley, and C. Brink. 1993. Response to anti-human IgE in human pulmonary arteries: regulation by the endothelium. Am. Rev. Respir. Dis. 147:1029-1033.
31. Kelly, L. J., B. J. Undem, and G. K. Adams. 1993. Antigen induced contraction of guinea pig isolated pulmonary arteries and lung parenchyma. J. Appl. Physiol. 74:1563-1569.
32. Hanna, C. J., M. K. Bach, P. D. Pare, and R. R. Schellenberg. 1981. Slow reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature (London) 290:343-344.
33. Schellenberg, R. R., and A. Foster. 1985. Differential activity of leukotrienes upon human pulmonary vein and artery. Prostaglandins 27:475-482.
34. 4. Fundam. Clin. Pharmacol. 1:433-444.
35. 4 on vascular strips from rabbits. Life Sci. 29:1325-1332.
36. 4. Biochem. Biophys. Res. Commun. 117:732-739.
37. 4 on human isolated saphenous veins. Br. J. Clin. Pharmacol. 34:409-414.
38. 4 relaxes canine renal and superior mesenteric arteries. Circ. Res. 57: 323-329.
39. 4-induced endothelium-dependent vasomotor relaxation and cGMP. J. Pharmacol. Exp. Ther. 245:47-52.
40. Sakuma, I., S. S. Gross, and R. Levi. 1987. Peptidoleukotrienes induced an endothelium-dependent relaxation of guinea pig main pulmonary artery and thoracic aorta. Prostaglandins 34:685-696.
41. 4 on cavian pulmonary artery and aorta. Ann. N.Y. Acad. Sci. 524:91-102.
42. IUPHAR. 1995. Receptor and ion channel nomenclature supplement. Trends Pharmacol. Sci. Suppl. 42-43.
43. 4 on the mechanical properties of the guinea pig basilar artery. Br. J. Pharmacol. 93:591-600.
44. Labat, C., J. L. Ortriz, X. Norel, I. Gorenne, J. Verley, T. S. Abrams, N. J. Cuthbert, S. R. Tudhope, P. Norman, P. J. Gardiner, and C. Brink. 1992. A second cysteinyl leukotriene receptor in human lung. J. Pharmacol. Exp. Ther. 263:800-805.
45. Gorenne, I., X. Norel, and C. Brink. 1996. Cysteinyl-leukotriene receptors in the human lung: what's new? Trends Pharmacol. Sci. 17:342-345.
46. Rinkema, L. E., C. R. Roman, E. L. VanAlstyne, S. M. Spaethe, and J. H. Fleisch. 1993. Contraction of guinea pig inferior vena cava by eicosanoids. Naunyn Schmiedeberg's Arch. Pharmacol. 348:520-525.
47. 4 evoked relaxation in canine renal artery and vein. Am. J. Physiol. 265:980-985.
48. Ortiz, J. L., I. Gorenne, J. Cortijo, A. Seller, C. Labat, B. Sarria, T. S. Abram, P. J. Gardiner, E. Morcillo, and C. Brink. 1995. Leukotriene receptors on human pulmonary vascular endothelium. Br. J. Pharmacol. 115:1382-1386.
49. 4 are potent endothelium dependent relaxing agents in canine splanchnic venous capacitance vessels. Circ. Res. 73:395-404.
50. Félétou, M., V. Girard, and E. Canet. 1995. Different involvement of nitric oxide in endothelium dependent relaxation of porcine pulmonary artery and vein: influence of hypoxia. J. Cardiovasc. Pharmacol. 25:665-673.
51. Goa, Y., H. Zhou, and J. U. Raj. 1995. Endothelium derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Circ. Res. 76:559-565.
52. Wallerstedt, S. M., and M. Bodelsson. 1997. Endothelium dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hypertension. Br. J. Pharmacol. 120:25-30.